SC
IDXX icon

Syon Capital’s Idexx Laboratories IDXX Stock Holding History

Syon Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$878K Buy
1,668
+311
+23% +$174K 0.04% 402
2026
Q1 		$762K Buy
1,357
+287
+27% +$184K 0.04% 398
2025
Q4 		$724K Buy
1,070
+54
+5% +$36.8K 0.04% 415
2025
Q3 		$649K Buy
1,016
+103
+11% +$62.5K 0.03% 395
2025
Q2 		$490K Sell
913
-63
-6% -$30.1K 0.03% 385
2025
Q1 		$410K Buy
976
+167
+21% +$72.5K 0.03% 348
2024
Q4 		$334K Buy
809
+57
+8% +$25K 0.03% 375
2024
Q3 		$380K Sell
752
-160
-18% -$77.7K 0.03% 329
2024
Q2 		$444K Buy
912
+170
+23% +$85.3K 0.04% 279
2024
Q1 		$401K Buy
742
+26
+4% +$14.2K 0.04% 302
2023
Q4 		$397K Buy
+716
New +$336K 0.04% 293

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Syon Capital's IDXX Position: Q2 2026 in Review

Syon Capital increased its Idexx Laboratories (IDXX) stake by 23% in Q2 2026, buying an estimated $174K and bringing the position to 1,668 shares worth $878K. The position accounts for 0.04% of the portfolio, ranked #402.

Syon Capital first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Syon Capital held 1,668 shares of Idexx Laboratories worth $878K as of Q2 2026.
  • Syon Capital bought 311 Idexx Laboratories shares in Q2 2026, an estimated $174K.
  • Idexx Laboratories made up 0.04% of Syon Capital's portfolio in Q2 2026, its #402 holding.
  • Syon Capital first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.